GlassScriptPhysician profile
George M Mccluskey
NPI 1205817467
$798.66
in general payments reported to CMS, 2019-2025
16 companies · $285 in 2025
The $285 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.28 · 2021: $58.45 · 2022: $179 · 2023: $36.87 · 2024: $224 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $246.32 | 2024-2025 | |
| Anika Therapeutics, INC. | $87.40 | 2022 | |
| Horizon Therapeutics Plc | $67.58 | 2021-2022 | |
| Medical Device Business Services, INC. | $62.73 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $44.86 | 2025 | |
| Bioventus LLC | $40.57 | 2021-2024 | Durolane |
| Solventum Corporation | $37.72 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Biocomposites INC | $36.97 | 2025 | Stimulan |
| Axogen | $27.33 | 2025 | |
| Innovation Technologies INC | $25.25 | 2024 | Irrisept |
| Atland Pharmaceuticals, LLC | $24.61 | 2024 | Tolmetin Sodium, Orphenadrine Citrate, Aspirin and Caffeine |
| Depuy Synthes Sales INC. | $24.01 | 2023 | Orthovisc |
| Intuitive Surgical, INC. | $22.70 | 2024 | |
| Endo Pharmaceuticals INC. | $22.47 | 2024 | Xiaflex |
| Pfizer INC. | $15.28 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12.86 | 2023 | Pico 14, Renasys Go V2 Home |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Mccluskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.